The role of the Raf/MAP kinase pathway in the development of androgen-insensitive prostate cancer
Prostate cancer is the second most commonly diagnosed cancer in the Western world and the second most common cause of male cancer-specific death. The development of novel therapies to treat androgen-insensitive prostate cancer (AIPC) has been hampered in the past by limited information regarding und...
Main Author: | |
---|---|
Published: |
University of Glasgow
2005
|
Subjects: | |
Online Access: | https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.437953 |